SILO
Silo Pharma, Inc. Common StockstockNASDAQ
silo pharma inc. (nasdaq: silo), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder, fibromyalgia, alzheimer's disease, parkinson's disease, and other rare neurological disorders. silo's mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry. silo is committed to developing innovative solutions to address a variety of underserved conditions. combining silo's resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space. silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.79 | 2026-11-10 | -6.14% | 5.293 |
| 1M | 1.18 | 2026-10-16 | +42.37% | 3.076 |
| 3M | 3.07 | 2026-08-17 | -45.28% | 2.286 |
| 6M | 5.82 | 2026-05-18 | -71.11% | 1.500 |
| 1Y | 6.13 | 2025-11-17 | -72.59% | 1.156 |
| 2Y | 14.85 | 2024-11-18 | -88.69% | — |
| 5Y | 133.65 | 2021-11-17 | -98.74% | 0.644 |
Silo Pharma, Inc. Common Stock (NASDAQ:SILO) stock price today is $1.68, and today's volume is 32,831. SILO is up 6.667% today. The 30 day average volume is 41,760. SILO market cap is $3.93M with 2.34M shares outstanding.